Literature DB >> 21927981

HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1.

David E Cochrane1, Robert E Carraway, Kimberly Harrington, Melissa Laudano, Stephen Rawlings, Ross S Feldberg.   

Abstract

OBJECTIVE AND
DESIGN: To determine if mast cells synthesize the inflammatory peptide, neurotensin (NT), secrete immunoreactive and bioactive NT, and express the NT receptor NTS1. MATERIALS: HMC-1 cells, pleural mast cells from Sprague-Dawley rats, LAD2 mast cells, and human cord blood mast cells were used. TREATMENT: HMC-1 cells were stimulated with NT, C48/80, mastoparan, or PGE(2). For changes in cutaneous vascular permeability, anesthetized rats were injected intravenously with Evans Blue dye and intradermally with saline, NT, histamine, diphenhydramine, and C48/80.
METHODS: RT-PCR was used to identify RNA transcripts. Histamine was measured by fluorometric assay. In vivo cutaneous vascular permeability assays, radio-immunoassays for NT, Western blotting for the NT precursor protein and NTS1 protein from HMC-1 cells and tissues from rats were used. Immunohistochemistry was used to identify NT precursor-like proteins in HMC-1 mast cells.
RESULTS: HMC-1 cells express mRNAs for NT precursor, PC5A processing enzyme and NTS1 receptor. Human cord blood mast cells and LAD2 mast cells express mRNA transcripts for NT precursor and NTS1. Western blotting showed NT precursor and NTS1 receptor in HMC1. Rat tissues with high numbers of mast cells contained NT precursor proteins. NT-like peptides from HMC-1 displayed NT-like bioactivity.
CONCLUSIONS: HMC-1 mast cells synthesize and secrete immunoreactive and bioactive NT-like peptide(s) and express the NT receptor, suggesting that NT from mast cells might serve autocrine and paracrine roles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21927981     DOI: 10.1007/s00011-011-0378-6

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  55 in total

1.  Mast cells have a protumorigenic role in human thyroid cancer.

Authors:  R M Melillo; V Guarino; E Avilla; M R Galdiero; F Liotti; N Prevete; F W Rossi; F Basolo; C Ugolini; A de Paulis; M Santoro; G Marone
Journal:  Oncogene       Date:  2010-08-23       Impact factor: 9.867

Review 2.  Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation.

Authors:  Dezheng Zhao; Charalabos Pothoulakis
Journal:  Peptides       Date:  2006-07-26       Impact factor: 3.750

3.  Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats.

Authors:  P J Cabot; L Carter; C Gaiddon; Q Zhang; M Schäfer; J P Loeffler; C Stein
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

4.  Mast cell secretion: differences between immunologic and non-immunologic stimulation.

Authors:  B R Rosengard; C Mahalik; D E Cochrane
Journal:  Agents Actions       Date:  1986-11

5.  Preformed angiotensin II is present in human mast cells.

Authors:  Masatake Hara; Koh Ono; Hiromi Wada; Shigetake Sasayama; Akira Matsumori
Journal:  Cardiovasc Drugs Ther       Date:  2004-11       Impact factor: 3.727

6.  The role of neurotensin in the uptake and distribution of fat.

Authors:  S Rosell
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

7.  Neurotensin is produced by and secreted from classic small cell lung cancer cells.

Authors:  T W Moody; D N Carney; L Y Korman; A F Gazdar; J D Minna
Journal:  Life Sci       Date:  1985-05-06       Impact factor: 5.037

8.  Evidence for a neurotensin receptor in rat serosal mast cells.

Authors:  R S Feldberg; D E Cochrane; R E Carraway; E Brown; R Sawyer; M Hartunian; D Wentworth
Journal:  Inflamm Res       Date:  1998-06       Impact factor: 4.575

9.  Characterization of large neuromedin-N using antisera towards regions of the neurotensin/neuromedin-N precursor.

Authors:  R E Carraway; S P Mitra; C Paradise
Journal:  Peptides       Date:  1991 May-Jun       Impact factor: 3.750

Review 10.  Critical role of mast cells in inflammatory diseases and the effect of acute stress.

Authors:  Theoharis C Theoharides; David E Cochrane
Journal:  J Neuroimmunol       Date:  2004-01       Impact factor: 3.478

View more
  6 in total

Review 1.  Stress-related skin disorders.

Authors:  Alex Alexopoulos; George P Chrousos
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

2.  Expression of neurotensin receptor-1 (NTS1) in primary breast tumors, cellular distribution, and association with clinical and biological factors.

Authors:  Clément Morgat; Véronique Brouste; Adrien Chastel; Valérie Vélasco; Gaétan Macgrogan; Elif Hindié
Journal:  Breast Cancer Res Treat       Date:  2021-10-01       Impact factor: 4.872

Review 3.  Key role of CRF in the skin stress response system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Blazej Zbytek; Desmond J Tobin; Theoharis C Theoharides; Jean Rivier
Journal:  Endocr Rev       Date:  2013-08-12       Impact factor: 19.871

4.  Neurotensin decreases the proinflammatory status of human skin fibroblasts and increases epidermal growth factor expression.

Authors:  Lucília Pereira da Silva; Bruno Miguel Neves; Liane Moura; Maria Teresa Cruz; Eugénia Carvalho
Journal:  Int J Inflam       Date:  2014-08-11

5.  Zika Virus Infects Human Placental Mast Cells and the HMC-1 Cell Line, and Triggers Degranulation, Cytokine Release and Ultrastructural Changes.

Authors:  Kíssila Rabelo; Antônio José da Silva Gonçalves; Luiz José de Souza; Anna Paula Sales; Sheila Maria Barbosa de Lima; Gisela Freitas Trindade; Bianca Torres Ciambarella; Natália Recardo Amorim Tasmo; Bruno Lourenço Diaz; Jorge José de Carvalho; Márcia Pereira de Oliveira Duarte; Marciano Viana Paes
Journal:  Cells       Date:  2020-04-16       Impact factor: 6.600

6.  Neurotensin and CRH interactions augment human mast cell activation.

Authors:  Konstantinos-Dionysios Alysandratos; Shahrzad Asadi; Asimenia Angelidou; Bodi Zhang; Nikolaos Sismanopoulos; Hailing Yang; Agatha Critchfield; Theoharis C Theoharides
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.